Home › Polycythemia Vera › Michigan
Polycythemia Vera clinical trials in Michigan
3 studies for Polycythemia Vera are looking for participants at sites in Michigan.
A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)
- University of Michigan ( Site 6000), Ann Arbor
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 10, 2026 · NCT06351631INTREPID: A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV)
- The Cancer and Hematology Centers, Grand Rapids
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 29, 2026 · NCT07429266A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms
- START Midwest, LLC, Grand Rapids
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 29, 2026 · NCT07469891From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.